A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis
Open Access
- 28 October 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 12 (1) , e2405597
Abstract
Doxorubicin (DOX), a potent antineoplastic agent, is commonly associated with cardiotoxicity, necessitating the development of strategies to reduce its adverse effects on cardiac function. Previous research has demonstrated a strong correlation between DOX‐induced cardiotoxicity and the activation of oxidative stress pathways. This work introduces a novel antioxidant therapeutic approach, utilizing libraries of tannic acid and N‐acetyl‐L‐cysteine‐protected bimetallic cluster nanozymes. Through extensive screening for antioxidative enzyme‐like activity, an optimal bimetallic nanozyme (AuRu) is identified that possess remarkable antioxidant characteristics, mimicking catalase‐like enzymes. Theoretical calculations reveal the surface interactions of the prepared nanozymes that simulate the hydrogen peroxide decomposition process, showing that these bimetallic nanozymes readily undergo OH⁻ adsorption and O₂ desorption. To enhance cardiac targeting, the atrial natriuretic peptide is conjugated to the AuRu nanozyme. These cardiac‐targeted bimetallic cluster nanozymes, with their anchoring capability, effectively reduce DOX‐induced cardiomyocyte ferroptosis and PANoptosis without compromising tumor treatment efficacy. Thus, the therapeutic approach demonstrates significant reductions in chemotherapy‐induced cardiac cell death and improvements in cardiac function, accompanied by exceptional in vivo biocompatibility and stability. This study presents a promising avenue for preventing chemotherapy‐induced cardiotoxicity, offering potential clinical benefits for cancer patients.Keywords
Funding Information
- National Natural Science Foundation of China (82370268)
- Natural Science Foundation of Henan Province (222300420073)
- Natural Science Foundation of Henan Province (242300421088)
- Henan Provincial Science and Technology Research Project (222301420051)
- Henan Provincial Science and Technology Research Project (225200810075)
- Henan Provincial Science and Technology Research Project (232301420061)
- Science and Technology Innovation Talents in Universities of Henan Province (2024HYTP048)
This publication has 35 references indexed in Scilit:
- A Single‐Atom Manganese Nanozyme Mn‐N/C Promotes Anti‐Tumor Immune Response via Eliciting Type I Interferon SignalingAdvanced Science, 2024
- A Cardiac‐Targeted Nanozyme Interrupts the Inflammation‐Free Radical Cycle in Myocardial InfarctionAdvanced Materials, 2023
- Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicityCell, 2023
- The Imbalance of p53–Park7 Signaling Axis Induces Iron Homeostasis Dysfunction in Doxorubicin‐Challenged CardiomyocytesAdvanced Science, 2023
- Nanozyme‐Enabled Treatment of Cardio‐ and Cerebrovascular DiseasesSmall, 2022
- Decoy Exosomes Offer Protection Against Chemotherapy‐Induced ToxicityAdvanced Science, 2022
- Advances in Antimicrobial Microneedle Patches for Combating InfectionsAdvanced Materials, 2020
- Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertensionBiomaterials, 2014
- The biological activity of auranofin: implications for novel treatment of diseasesInflammopharmacology, 2012
- Attenuation of doxorubicin-induced contractile and mitochondrial dysfunction in mouse heart by cellular glutathione peroxidaseFree Radical Biology and Medicine, 2006